Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 25,039 | 23,475 | 22,758 | 22,813 | 17,299 |
| Cost of Goods | 4,597 | 4,500 | 3,697 | 3,028 | 2,673 |
| Gross Profit | 20,442 | 18,975 | 19,061 | 19,785 | 14,626 |
| Operating Expenses | 36,210 | 31,289 | 28,568 | 24,097 | 18,331 |
| Operating Income | -15,171 | -11,814 | -8,810 | -4,284 | -3,032 |
| Interest Expense | 0 | 0 | 0 | 0 | 395 |
| Other Income | 16 | 23 | 24 | 4 | -1,378 |
| Pre-tax Income | -15,155 | -11,791 | -8,786 | -4,280 | -4,805 |
| Income Tax | -8,725 | N/A | 5 | N/A | N/A |
| Net Income Continuous | -6,430 | -11,791 | -8,791 | -4,280 | -4,889 |
| Net Income | $-6,430 | $-11,791 | $-8,791 | $-4,280 | $-4,889 |
| EPS Basic Total Ops | -0.25 | -0.47 | -0.35 | -0.17 | -0.26 |
| EPS Basic Continuous Ops | -0.26 | -0.47 | -0.35 | -0.17 | -0.27 |
| EPS Diluted Total Ops | -0.25 | -0.47 | -0.35 | -0.17 | -0.26 |
| EPS Diluted Continuous Ops | -0.26 | -0.47 | -0.35 | -0.17 | -0.27 |
| EBITDA(a) | $-13,720 | $-10,725 | $-8,176 | $-4,051 | $-2,699 |